全文获取类型
收费全文 | 4074篇 |
免费 | 163篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 182篇 |
儿科学 | 88篇 |
妇产科学 | 121篇 |
基础医学 | 595篇 |
口腔科学 | 35篇 |
临床医学 | 362篇 |
内科学 | 1062篇 |
皮肤病学 | 13篇 |
神经病学 | 306篇 |
特种医学 | 125篇 |
外科学 | 497篇 |
综合类 | 31篇 |
一般理论 | 3篇 |
预防医学 | 202篇 |
眼科学 | 77篇 |
药学 | 303篇 |
中国医学 | 2篇 |
肿瘤学 | 260篇 |
出版年
2023年 | 18篇 |
2022年 | 14篇 |
2021年 | 241篇 |
2020年 | 66篇 |
2019年 | 109篇 |
2018年 | 137篇 |
2017年 | 87篇 |
2016年 | 104篇 |
2015年 | 118篇 |
2014年 | 173篇 |
2013年 | 221篇 |
2012年 | 325篇 |
2011年 | 372篇 |
2010年 | 175篇 |
2009年 | 116篇 |
2008年 | 246篇 |
2007年 | 251篇 |
2006年 | 291篇 |
2005年 | 243篇 |
2004年 | 240篇 |
2003年 | 206篇 |
2002年 | 159篇 |
2001年 | 24篇 |
2000年 | 22篇 |
1999年 | 31篇 |
1998年 | 18篇 |
1997年 | 14篇 |
1996年 | 19篇 |
1995年 | 13篇 |
1994年 | 7篇 |
1993年 | 11篇 |
1992年 | 10篇 |
1991年 | 12篇 |
1990年 | 24篇 |
1989年 | 10篇 |
1988年 | 13篇 |
1987年 | 15篇 |
1986年 | 7篇 |
1985年 | 10篇 |
1984年 | 13篇 |
1983年 | 6篇 |
1980年 | 4篇 |
1978年 | 10篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1971年 | 5篇 |
1970年 | 4篇 |
1968年 | 4篇 |
1967年 | 5篇 |
1966年 | 5篇 |
排序方式: 共有4264条查询结果,搜索用时 31 毫秒
41.
42.
Leinonen E Skarstein J Behnke K Agren H Helsdingen JT 《International clinical psychopharmacology》1999,14(6):329-337
We aimed to compare the antidepressant and anxiolytic effects, tolerability and effects on quality of life of mirtazapine and citalopram in a randomized, double-blind, multicentre, 8-week study. Patients with a Major Depressive Episode (DSM-IV) and a baseline score of > or = 22 on the Montgomery-Asberg Depression Rating Scale (MADRS) were randomized to 8 weeks treatment with either mirtazapine (n = 137, 15-60 mg/day) or citalopram (n = 133, 20-60 mg/day). Efficacy was evaluated by the MADRS, Hamilton Anxiety Scale (HAM-A), Clinical Global Impression scales (CGI), the Leeds Sleep Evaluation Questionnaire (LSEQ) and Quality of Life Enjoyment and Satisfaction Questionnaire (QLESQ). The efficacy analyses were performed on the Intent-To-Treat Group using the Last Observation Carried Forward method. Vital signs and laboratory variables are measured and adverse events recorded at each weekly visit. The magnitude of reduction from baseline in group mean MADRS scores was large in both groups, reaching after 8 weeks of treatment mean scores of 9.1 in the mirtazapine group and 8.9 in the citalopram group. Both treatments also resulted in a substantial improvement in anxiety symptoms, sleep disturbances and quality of life, and high percentage of responders. However, at day 14, statistically significantly larger magnitudes of change favouring mirtazapine were present in the group mean MADRS, HAM-A and CGI-Severity of illness and Quality of life scores. A difference of 2.3 points on MADRS favouring mirtazapine is considered indicative for a clinically relevant superiority between two proven antidepressants. Mirtazapine treatment was also related to faster improvement of sleep, quality of sleep and improved alertness following awakening, as shown by statistically significant differences on the self-rating LSEQ at various time points. There were no differences between two treatment groups on self-rating QLSEQ. Both drugs were well tolerated, with a low number of patients in either group prematurely terminating the study due to adverse events (mirtazapine: 3.6%, citalopram, 3.0%). Sweating and nausea were statistically significantly more frequent in the citalopram group and increased appetite and complaints of weight increase in the mirtazapine group. There were no clinically relevant changes in laboratory parameters and vital sign variables with either treatment, except for clinically relevant increase in body weight, occurring more frequently in mirtazapine patients. In this study, mirtazapine and citalopram were equally effective in reducing symptoms of depression and anxiety, and well tolerated. However, mirtazapine was significantly more effective than citalopram after 2 weeks of treatment on the MADRS, HAM-A and CGI Severity of illness and Quality of life scales. This finding, consistently present at all major efficacy variables, suggests potentially faster onset of efficacy of mirtazapine over citalopram. 相似文献
43.
Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. 总被引:2,自引:0,他引:2
Marcin Makowski Tomasz Grzela Justyna Niderla Maciej ?Azarczyk Pawe? Mróz Maciej Kopeé Magdalena Legat Katarzyna Strusińska Katarzyna Koziak Dominika Nowis Piotr Mrówka Maria Wasik Marek Jakóbisiak Jakub Go?ab 《Clinical cancer research》2003,9(14):5417-5422
PURPOSE: The aim of the present study was to potentiate the antitumor effectiveness of photodynamic therapy (PDT). A cDNA microarray analysis was used to evaluate the gene expression pattern after Photofrin-mediated PDT to find more effective combination treatment with PDT and inhibitor(s) of the identified gene product(s) overexpressed in tumor cells. EXPERIMENTAL DESIGN: Atlas Mouse Stress Array was used to compare the expression profile of control and PDT-treated C-26 cells. The microarray results have been confirmed using Western blotting. Cytostatic/cytotoxic in vitro assay as well as in vivo tumor models were used to investigate the antitumor effectiveness of PDT in combination with cyclooxygenase (COX) 2 inhibitors. RESULTS: PDT induced the expression of 5 of 140 stress-related genes. One of these genes encodes for COX-2, an enzyme important in the tumor progression. Inhibition of COX-2 in vitro with NS-398, rofecoxib, or nimesulide, or before PDT with nimesulide did not influence the therapeutic efficacy of the treatment. Administration of a selective COX-2 inhibitor after PDT produced potentiated antitumor effects leading to complete responses in the majority of treated animals. CONCLUSIONS: COX-2 inhibitors do not sensitize tumor cells to PDT-mediated killing. However, these drugs can be used to potentiate the antitumor effectiveness of this treatment regimen when administered after tumor illumination. 相似文献
44.
Margaret K. Hargreaves PhD Maciej S. Buchowski PhD Robert E. Hardy MD MPH Susan R. Rossi RN PhD Joseph S. Rossi PhD 《American journal of obstetrics and gynecology》1997,176(6):s255
Modification of dietary fat and fiber could help prevent cancers of the breast, endometrium, and ovary that are prevalent in African-American women. Dietary intervention programs aimed at reducing fat intake have had mixed results in this population. The transtheoretic model is proposed for achieving dietary change. Strategies for changing health behaviors in African-American women include heightening sensitivity to cultural values among health educators and the use of multiple strategies to reinforce messages. To stimulate healthier eating, it is important to incorporate the distinct habitual eating patterns into innovative intervention methods, using effective behavioral change methods. (Am J Obstet Gynecol 1997;176:S255-64.) 相似文献
45.
46.
Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates. 总被引:2,自引:0,他引:2
Pawel Surowiak Verena Materna Malgorzata Drag-Zalesinska Andrzej Wojnar Irina Kaplenko Marek Spaczyński Manfred Dietel Maciej Zabel Hermann Lage 《International journal of gynecological pathology》2006,25(2):131-139
High cytoplasmic expression of maspin was described in ovarian cancers of shorter survival rates. Until now, no relationship has been described between expression of maspin and sensitivity to cisplatin in ovarian cancers. This study aimed at examining the relationship between expression of maspin, detected by immunohistochemistry and clinical response to cisplatin in ovarian cancer cases as well as the in vitro sensitivity to cisplatin of 11 ovarian cancer cell lines. The analyzes were performed on 73 samples of ovarian cancer and on A2780P, A2780RCIS, CAOV-3, EFO 21, EFO 27, ES-2, Mdah 2774, OAW 42, OVCAR-3, PA-1, and SKOV-3 ovarian cancer cells. Cytoplasmic maspin expression in studied cells significantly correlated with cisplatin sensitivity. A significantly shorter overall survival and progression-free survival was associated with lower cytoplasmic maspin expression at first-look laparotomies and nuclear maspin expression and secondary cytoreductions. Higher nuclear maspin at first-look laparotomies expression was specific for cases of complete response. In the study, the elevated expression of maspin was shown to be typical for cisplatin-sensitive ovarian cancers. 相似文献
47.
Resch B. Eber E. Ehringer-Schetitska D. Kiechl-Kohlendorfer U. Michel‑Behnke I. Popow-Kraupp T. Redlberger-Fritz M. Seidel M. Strenger V. Wald M. Zacharasiewicz A. Berger A. 《P?diatrie und P?dologie》2019,54(6):270-276
Pädiatrie & Pädologie - Im Rahmen eines industrieunabhängigen Expertenkreises wurden die Empfehlungen zur Respiratory-Syncytial-Virus(RSV)-Prophylaxe mit Palivizumab der... 相似文献
48.
49.
Nitric oxide (NO) production and carbon monoxide (CO) production are increased in inflammatory lung diseases. Although there
are some pieces of evidence for hormonal modulation by estrogen, little is known about exhaled NO and CO during the ovarian
cycle. In 23 subjects, we measured exhaled NO and CO by an online analyzer. Significantly higher levels of exhaled NO were
found at the midcycle compared with those in the premenstrual period or during menstruation. Higher levels of CO were after
ovulation and reached a peak in the premenstrual phase. The lowest levels of CO were observed in the first days of the estrogen
phase. In males, there was no significant variation in exhaled NO and CO. Exhaled NO and CO levels vary during the ovarian
cycle in women, and this fact should be taken into account during serial measurements of these markers in the female population. 相似文献
50.
Katarzyna Drożdż Irmina Grzegorek Magdalena Chmielewska Agnieszka Gomułkiewicz Karolina Jabłońska Aleksandra Piotrowska Maciej Karczewski Dariusz Janczak Dariusz Patrzałek Piotr Dzięgiel Andrzej Szuba 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2014,122(9):742-749
Nogo‐B (Reticulon 4B) is considered to be a novel vascular marker, which may have a protective role in injury‐induced neointima formation and atherosclerosis. Nogo A/B is found to be crucial for monocyte/macrophage recruitment in acute inflammation and it is expressed in CD68 + macrophages. We hypothesize that macrophage infiltration in atherosclerosis is not dependent on Nogo‐B expression in arterial wall. We have assessed Nogo‐B expression and macrophage accumulation in the iliac arteries of healthy organ donors and organ donors with cardiovascular risk factors. Paraffin sections of 66 iliac arteries, from 44 deceased organ donors (17 women and 27 men), were studied. The healthy and cardiovascular risk (CVR) subgroups were created. With regard to staging of the atherosclerotic process, the thickness of arterial intima was measured in digitalized images of H+E stained tissue sections. Immunohistochemical reactions (Nogo‐B and CD68) were carried out in all arteries (66 samples). Western blotting (WB‐19 samples) and real‐time PCR (27 samples) were performed on selected arteries. Significantly higher Nogo‐B expression was demonstrated in the intima of the healthy subjects' subgroup, using immunohistochemistry. WB and real‐time PCR revealed a trend toward lower Nogo‐B expression in the adventitia of the CVR subgroup. Furthermore, the thickness of the intima was found to negatively correlate with the expression of Nogo‐B in the intima and media (r = ?0.32; p < 0.05; r = ?0.32; p < 0.05). Macrophage infiltrates were more prominent in intima of CVR subjects (0.65 vs 3.52 a.u.; p < 0.01). Macrophage density in intima increased with atherosclerosis progression (r = 0.37; p < 0.01). CD68 macrophages density in adventitia was lower in CVR arteries than in healthy arteries. The expression of Nogo‐B, in arterial intima, is impeded in the early stages of atherosclerosis. Accumulation of arterial intimal CD68 macrophages has been shown to progress; however, the overall macrophage density in the adventitia is reduced in arteries shown to have intimal thickening. Macrophage infiltration is not accompanied by Nogo‐B expression in atherosclerotic arteries. 相似文献